U.S. markets closed

Vilmorin & Cie (4HL.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
49.20-0.05 (-0.10%)
At close: 03:36PM CET
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close49.25
Bid49.05 x 15000
Ask49.85 x 15000
Day's Range49.00 - 49.25
52 Week Range38.65 - 55.50
Avg. Volume42
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for 4HL.SG

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Sales on September 30, 2022

      Activity: driven by Field Seeds, sales for activities intended for professional markets rose sharply Objectives for 2022-2023: Vilmorin & Cie confirms its objectives for the fiscal year News: Filing of the Universal Registration Document for 2021-2022Preparation of the Combined Annual General Meeting (Ordinary and Extraordinary) of December 9, 2022 Vilmorin & Cie’s consolidated sales for the first quarter of 2022-2023, closing on September 30, 2022, corresponding to revenue from ordinary activit

    • GlobeNewswire

      Results for the fiscal year on June 30, 2022

      Vilmorin & Cie once again demonstrates the resilience of its model by achieving solid commercial and financial performances Proposal of a dividend of 1.60 euros per share at the upcoming Annual General Meeting of Shareholders, in Auvergne News: a new research partnership concerning pulses in Canada Objectives for 2022-2023: business growth of between 6% and 8%* and a current operating margin rate of at least 8% *On a like-for-like basis. Financial statements for fiscal year 2021-2022:Vilmorin &

    • GlobeNewswire

      Sale for the fiscal year on June 30, 2022

      Business: Vilmorin & Cie manages to exceed its consolidated sales growth objective for the year, in spite of a general destabilized context News: Update on the situation in Ukraine and in RussiaVilmorin & Cie announces the signing of a new research partnership in Canada concerning pulsesAnthony CARVALHO, appointed Vilmorin & Cie's Chief Financial Officer as of September 14, 2022 Outlook for the end of 2021-2022 Closing on June 30, 2022, Vilmorin & Cie's sales for the fourth quarter, correspondin